DK1005353T3 - Farmaceutisk præparat omfattende Lactobacillus casei rhamnosus - Google Patents

Farmaceutisk præparat omfattende Lactobacillus casei rhamnosus

Info

Publication number
DK1005353T3
DK1005353T3 DK98928734T DK98928734T DK1005353T3 DK 1005353 T3 DK1005353 T3 DK 1005353T3 DK 98928734 T DK98928734 T DK 98928734T DK 98928734 T DK98928734 T DK 98928734T DK 1005353 T3 DK1005353 T3 DK 1005353T3
Authority
DK
Denmark
Prior art keywords
lactobacillus casei
pharmaceutical composition
casei rhamnosus
rhamnosus
preparation
Prior art date
Application number
DK98928734T
Other languages
Danish (da)
English (en)
Inventor
Hakansson Eva Grahn
Stellan Hakansson
Original Assignee
Essum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Essum Ab filed Critical Essum Ab
Application granted granted Critical
Publication of DK1005353T3 publication Critical patent/DK1005353T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/125—Casei
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/245—Lactobacillus casei

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
DK98928734T 1997-06-02 1998-06-02 Farmaceutisk præparat omfattende Lactobacillus casei rhamnosus DK1005353T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9702083A SE511524C2 (sv) 1997-06-02 1997-06-02 Lactobacillus casei rhamnosus-stam samt farmaceutisk beredning för bekämpning av patogena tarmbakterier
EP98928734A EP1005353B1 (en) 1997-06-02 1998-06-02 Pharmaceutical preparation comprising lactobacillus casei rhamnosus
PCT/SE1998/001041 WO1998055131A1 (en) 1997-06-02 1998-06-02 Pharmaceutical preparation comprising lactobacillus casei rhamnosus

Publications (1)

Publication Number Publication Date
DK1005353T3 true DK1005353T3 (da) 2005-10-03

Family

ID=20407203

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98928734T DK1005353T3 (da) 1997-06-02 1998-06-02 Farmaceutisk præparat omfattende Lactobacillus casei rhamnosus

Country Status (12)

Country Link
EP (1) EP1005353B1 (es)
JP (1) JP4350170B2 (es)
CN (1) CN1153575C (es)
AT (1) ATE304366T1 (es)
AU (1) AU726217B2 (es)
CA (1) CA2291623A1 (es)
DE (1) DE69831578T2 (es)
DK (1) DK1005353T3 (es)
ES (1) ES2245801T3 (es)
NO (1) NO326122B1 (es)
SE (1) SE511524C2 (es)
WO (1) WO1998055131A1 (es)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1034787A1 (en) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
MXPA02007018A (es) * 2000-01-18 2002-12-13 Nestle Sa Composicion alimenticia para mascotas para tratamiento de la especie helicobacter en mascotas.
FR2808689B1 (fr) 2000-05-11 2004-09-03 Agronomique Inst Nat Rech Utilisation de souches acetogenes hydrogenotrophes pour la prevention ou le traitement de troubles digestifs
CN1444484A (zh) * 2000-06-19 2003-09-24 穆科普罗泰科有限公司 用益生菌对粘膜表面的细菌或病毒感染进行治疗或免疫治疗及用于此的组合物
BR0006628A (pt) * 2000-12-07 2004-06-22 Sanab Saneamento Ambiental E B Sistema anaeróbico de tratamento de lixo urbano, resìduos agro-industrias e biomassa
KR100449597B1 (ko) * 2000-12-08 2004-09-18 (주) 피엘바이오 헬리코박터 필로리의 활성을 억제하는 유산균
AU7675601A (en) * 2000-12-08 2002-06-18 Pl Bio Co Ltd Lactic acid bacteria with inhibiting activities on (helicobacter pylori)
WO2002045727A1 (en) * 2000-12-08 2002-06-13 Plbio Co., Ltd. Lactic acid bacteria inhibiting adhesion of helicobacter pylori to gastric mucosa
KR100424790B1 (ko) * 2000-12-08 2004-03-30 (주) 피엘바이오 헬리코박터 필로리의 활성을 억제하는 유산균
US7214370B2 (en) 2000-12-18 2007-05-08 Probiohealth, Llc Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
EP1345613B1 (en) 2000-12-18 2008-04-09 Probio Health Probiotic compounds derived from lactobacillus casei strain ke01
SG97174A1 (en) * 2000-12-19 2003-07-18 Cell Biotechnology Food Co Ltd Lactobacillus rhamnosus strain and uses thereof
JPWO2002055092A1 (ja) * 2001-01-16 2004-05-13 天藤製薬株式会社 消化管疾患の予防及び／又は治療剤
DK1570060T3 (da) * 2002-12-02 2007-11-05 Basf Ag L-rhamnoseinducerbare ekspressionssystemer
US7125963B2 (en) 2004-03-03 2006-10-24 En N Tech Inc Treatments for contaminant reduction in lactoferrin preparations and lactoferrin containing compositions
WO2007108763A1 (en) * 2006-03-17 2007-09-27 Probac Ab Use of lactobacillus strains for promoting immunotolerance in autoimmune disease
EP1996696B1 (en) * 2006-03-17 2016-12-21 Probi Aktiebolag Thermostable lactobacillus strains
CN101173228B (zh) * 2006-11-01 2011-08-17 信谊药厂 新的乳酸杆菌菌株、药物组合物及其用途、以及制造方法
FR2928935B1 (fr) * 2008-03-19 2011-05-20 Gervais Danone Sa Souche de lactobacillus rhamnosus.
EP2349295B8 (en) * 2008-11-17 2016-12-14 Winclove Holding B.V. Pharmaceutical preparation comprising a combination of streptococcus strains and lactobacillus strains
RU2509478C2 (ru) * 2008-12-05 2014-03-20 Нестек С.А. Пробиотическая композиция, предназначенная для младенцев с низкой массой тела при рождении
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
EP2604123A1 (en) 2011-12-15 2013-06-19 Friesland Brands B.V. Method and nutritional compositions for the treatment of diarrhea.
US20130344042A1 (en) * 2012-06-20 2013-12-26 Gretchen Tanbonliong Dietary management of celiac disease and food allergy
EP2923704B1 (en) 2012-11-16 2024-03-20 Asahi Group Holdings, Ltd. Stress-induced bowel disorder-relieving agent comprising specific lactobacillus gasseri strain or treatment product thereof
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
NO3065748T3 (es) 2014-12-23 2018-04-21
SI3193901T1 (en) 2014-12-23 2018-06-29 4D Pharma Research Limited Pirin polypeptide and immune modulation
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
SG10201912324XA (en) 2015-06-15 2020-02-27 4D Pharma Res Ltd Compositions comprising bacterial strains
HUE044617T2 (hu) 2015-06-15 2019-11-28 4D Pharma Res Ltd Baktériumtörzseket tartalmazó készítmények
ME03563B (me) 2015-06-15 2020-07-20 4D Pharma Res Ltd Kompozicije koje sadrže bakterijske sojeve
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
MD3209310T2 (ro) 2015-11-20 2018-06-30 4D Pharma Res Ltd Compoziții care conțin tulpini bacteriene
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
CN114712405A (zh) 2016-03-04 2022-07-08 4D制药有限公司 包含细菌菌株的组合物
TWI802545B (zh) 2016-07-13 2023-05-21 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
EP3630137B1 (en) 2017-05-22 2023-05-17 4D Pharma Research Limited Compositions comprising bacterial strains
MA41708A (fr) 2017-05-24 2020-04-08 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
PL3600364T3 (pl) 2017-06-14 2021-01-11 4D Pharma Research Limited Kompozycje zawierające szczep bakteryjny z rodzaju megasphaera i ich zastosowania
SI3638271T1 (sl) 2017-06-14 2021-01-29 4D Pharma Research Limited Sestavki, ki vsebujejo bakterijske seve
CN109182166B (zh) * 2018-08-27 2021-08-20 南昌大学 一株具有缓解便秘功效的鼠李糖乳杆菌及其应用
CN110295130A (zh) * 2019-07-29 2019-10-01 诺佰克（武汉）生物科技有限公司 一株鼠李糖乳杆菌及其应用
CN113088470A (zh) * 2021-04-14 2021-07-09 广东医科大学 一株鼠李糖乳杆菌L.rB16及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2421066A1 (de) * 1974-05-02 1976-03-25 Solco Basel Ag Bifidobakterien enthaltendes praeparat
AU624067B2 (en) * 1986-12-12 1992-06-04 Biorem C.C. Preparation suitable for use in the treatment of enteric disorders
SE469875C (sv) * 1991-07-25 1997-02-05 Probi Ab Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen

Also Published As

Publication number Publication date
CA2291623A1 (en) 1998-12-10
AU726217B2 (en) 2000-11-02
CN1153575C (zh) 2004-06-16
WO1998055131A1 (en) 1998-12-10
SE9702083D0 (sv) 1997-06-02
NO995794L (no) 2000-01-31
NO326122B1 (no) 2008-09-29
EP1005353A1 (en) 2000-06-07
ES2245801T3 (es) 2006-01-16
DE69831578D1 (de) 2005-10-20
NO995794D0 (no) 1999-11-26
JP2002507200A (ja) 2002-03-05
JP4350170B2 (ja) 2009-10-21
CN1272791A (zh) 2000-11-08
SE511524C2 (sv) 1999-10-11
AU8046098A (en) 1998-12-21
ATE304366T1 (de) 2005-09-15
EP1005353B1 (en) 2005-09-14
DE69831578T2 (de) 2006-04-27
SE9702083L (sv) 1998-12-03

Similar Documents

Publication Publication Date Title
DK1005353T3 (da) Farmaceutisk præparat omfattende Lactobacillus casei rhamnosus
DK1436380T3 (da) Sammensætning omfattende en lactobacillusstamme samt anvendelser deraf
MXPA04000808A (es) Cepas probioticas de lactobacillus salivarius.
AU2613995A (en) Lactobacillus strains of human origin, their compositions and uses thereof
HRP20030586B8 (en) Combination of probiotics
DE69839699D1 (de) Vaginales lactobacillus-medikament
EA200101262A1 (ru) Диетическая или фармацевтическая композиция для применения в целях профилактики или лечения гипероксалурии
BR9916062A (pt) Administração oral de lactobacillus para o tratamento e prevenção de infecção urogenital
EE9700269A (et) Farmatseutiline kompositsioon, mis sisaldab Lactobacillus plantarum'it ja arginiini
TW365538B (en) Pharmaceutical composition for preventing a bacterial disease of fishes and crustaceans
EA200200704A1 (ru) Ослабленные микроорганизмы для лечения инфекции
DE69922639D1 (de) Enterotoxindefizierende bacillus
RU92015133A (ru) Консорциум бактерий (lactobacillus salivarius var. salivaris lactobacillus acidophilus, lactobacillus lactis) 3843 для активации фотосинтеза
IT1269838B (it) Ceppi di lattobacilli di origine umana e loro usi
LV5677A3 (lv) Bakteriju lactobacillus casei var. alactosus celms - L(+)-pienskabes producents izmantojams lopbaribas konservesanai
GEP20033132B (en) Bacteriological Preparations
MD20010055A (ro) Preparat microbian sanogenic pentru profilaxia şi tratamentul disbacteriozei intestinale
IT1274733B (it) Ceppo del genere lactobacillus di origine umana e suoi usi
MD669F1 (ro) Tulpina a bacteriilor Lactobacillus Acidophilus utilizata la prepararea eubioticelor The bacteria strain Lactobacillus acidophilus used for eubiotics preparation
BG100055A (en) Kalfinella sacoidosis sp. novo strain for making preparations for allergological, serological and immunological diagnosis of sarcoidosis, crohn's disease and mediterranean fever